These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23103705)

  • 1. Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure.
    Caruso R; De Chiara B; Campolo J; Verde A; Musca F; Belli O; Parolini M; Cozzi L; Moreo A; Frigerio M; Parodi O
    Clin Biochem; 2013 Jan; 46(1-2):94-8. PubMed ID: 23103705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A
    Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
    Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
    Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
    Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
    Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
    Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
    Stanciu AE; Stanciu MM; Vatasescu RG
    Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Defensins and outcome in patients with chronic heart failure.
    Christensen HM; Frystyk J; Faber J; Schou M; Flyvbjerg A; Hildebrandt P; Raymond I; Klausen TW; Kistorp C
    Eur J Heart Fail; 2012 Apr; 14(4):387-94. PubMed ID: 22357441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of neopterin concentration in patients with heart failure].
    Wetlicka I; Korzeniowska K; Bogdański P; Kazmierczak M; Chmara E; Musialik K; Jabłecka A
    Pol Merkur Lekarski; 2010 Apr; 28(166):256-9. PubMed ID: 20491332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.